Efficacy and safety of tolvaptan in rapidly progressing autosomal dominant polycystic kidney disease: a single-center, prospective, single-arm study. [PDF]
Zhou L, Li W.
europepmc +1 more source
GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease. [PDF]
Wu SS +5 more
europepmc +1 more source
Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study. [PDF]
Zhou L, Li W.
europepmc +1 more source
Genetic testing in autosomal dominant polycystic kidney disease: why it matters in 2025. [PDF]
Cornec-Le Gall E, Ong ACM.
europepmc +1 more source
Clinical Factors Associated With Intracranial Aneurysms in Patients With Autosomal Dominant Polycystic Kidney Disease. [PDF]
Fuchinoue Y +7 more
europepmc +1 more source
Unravelling sex-specific differences in autosomal dominant polycystic kidney disease: a multiorgan perspective. [PDF]
Furlano M +9 more
europepmc +1 more source
Quantitative dynamic contrast-enhanced magnetic resonance imaging for renal perfusion measurement in autosomal dominant polycystic kidney disease. [PDF]
Onuoha EE +4 more
europepmc +1 more source
Related searches:
Autosomal Dominant Polycystic Kidney Disease
Primary Care: Clinics in Office Practice, 2020Autosomal Dominant Polycystic Kidney Disease is an inherited multisystemic disorder of the renal tubules with subsequent formation of multiple cysts and enlargement of the kidney, affecting various organs. Diagnosis is initially suspected in those with family history and/or individuals who develop hypertension early on (secondary hypertension) or ...
Parvathi, Perumareddi, Darin P, Trelka
openaire +2 more sources

